Market Research Logo

Global Biologics Drug Development Market: Focus on Facility, Service, Product Type, Country Analysis, and Market Dynamics - Analysis and Forecast, 2018-2027

Global Biologics Drug Development Market: Focus on Facility, Service, Product Type, Country Analysis, and Market Dynamics - Analysis and Forecast, 2018-2027

The pharmaceutical industry is a multibillion market consisting of innovator drugs and generics. The pharmaceutical market consists of companies involved in the research, development, manufacturing, and commercialization of drugs for human and animal use. The evolving healthcare needs across the world has led to the rise of novel medication for the treatment of various chronic diseases. Biologics is one such type of medication with proven efficacy and safety.

Biologics are defined as pharmaceutical products obtained from living cells or microorganisms. These are complex and large molecules consisting of proteins, peptides, nucleic acids, sugars, and cellular structures or a combination of these. The pharmaceutical industry is shifting toward biologic drug products due to their advantages over small molecule such as minimal toxicity and safety issues, high target specificity, and better understood mechanism of action. These factors prompt increased interest in the biologics; hence, there is a higher trend toward their discovery and development process.

The biologics drug development involves different types of services for the development of biologics as well as facility for their manufacture. The market can be segmented based on facility into in-house, outsource, and PharmaExcess. Based on services the market can be segmented into clinical manufacturing, formulation development, bioassay development, and analytical services. Based on the product class, monoclonal antibody is anticipated to be the major contributor to the market. However, the fastest growing segment is expected to be growth factors market. Geographically, the market is segmented into four regions namely, North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World.

The purpose of the study is to gain a holistic view of the biologics drug development market in terms of various factors influencing it such as recent trends, technological advancements, and regulatory aspects of the market. The scope of the report is centered upon conducting a detailed study of the solutions allied with the biologics drug development market. The market has been segmented into ‘product class’, ‘facility’, ‘services’, and ‘geographical regions’. The report offers the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering into the market.

This research report aims at answering various aspects of the global biologics drug discovery market with the help of key factors driving the market, threats that can possibly inhibit the overall market growth, and the current growth opportunities that is going to shape the future trajectory of the market expansion.

The answers to the following key questions can be derived from this report:

  • What are the major market drivers, challenges, and opportunities in the global biologics drug development market and their case studies?
  • What were the market shares of the leading segments and sub-segments of the global biologics drug discovery market in 2017, and what will be the shares in 2027?
  • How will each segment of the global biologics drug development market grow during the forecast period, and what will be the revenue generated by each of the segments by the end of 2027?
  • What are the influencing factors that may affect the market share of the key players?
  • How will the industry evolve during the forecast period between 2017 and 2027?
  • What are the key developmental strategies implemented by the key players to stand out in this market?
  • What will be the growth rate of the PharmaExcess segment during the forecast period?
  • Who are the key outsourced manufacturers of the biologics drug development market?
  • How the market has been segmented on the basis of services? Which service is highly adopted in the biologics drug development process?
  • Which geographical location will contribute to the highest revenue generation of the biologics drug development market?
The key players of the market include Abbvie, Inc., Allergan Plc, Boehringer Ingelheim International GmbH, Charles River Laboratories, Catalent Inc., Lonza Group, MabPlex Inc., Samsung Biologics, and Amgen, Inc., among others.


Executive Summary
1 Market Overview
1.1 Biologics Drug Development
1.2 Biologics Drug Development: Key Trends
1.3 Integrated Discovery, Development, and commercialization of Biologics
1.4 Clinical Developmental Stages of Biologics
1.5 Manufacturing Stages of Biologics
1.6 Process Development
1.7 Bio Manufacturing Process
1.8 Formulation Development
1.9 Biologics In-House Drug Development Market
1.9.1 North America
1.9.2 Europe
1.9.3 Asia-Pacific
1.10 Biologics Outsourcing Drug Development Market
1.10.1 North America
1.10.2 Europe
1.10.3 Asia-Pacific
1.11 Biologics Drug Development Cost
2 Market Dynamics
2.1 Market Drivers
2.2 Market Restraints
2.3 Market Opportunities
3 Competitive Landscape
3.1 Key Developmental Strategies
3.1.1 Acquisitions
3.1.2 Agreements, Partnership, Collaboration and Joint Ventures
3.1.3 Approvals
3.1.4. Clinical Study
3.1.5 Business Expansion
3.1.6 Product Launch
3.1.7 Awards
3.2 Porter’s Five Forces Analysis
4 Biologics Drug Development Market, (by Class)
4.1 Overview
4.1.1 Monoclonal Antibodies (mAbs)
4.1.2 Hormones
4.1.3 Growth Factors
4.1.4 Cytokines and Fusion Proteins
4.1.5 Therapeutic Enzymes
4.1.6 Blood Factors and Anticoagulants
4.1.7 Vaccines
5 Biologics Drug Development Market, (by Facility)
5.1 Overview
5.1.1 In-House
5.1.2 Outsource
5.1.3 Pharma Excess
6 Biologics Drug Development Market, (by Services)
6.1 Overview
6.1.1 Clinical Manufacturing
6.1.1.1 Cell Bank Preparation and Cell Line Development
6.1.1.2 Cell Culture Upstream Development
6.1.1.3 Purification Downstream Development
6.1.2 Formulation Development
6.1.3 Bioassay Development
6.1.4 Analytical Services
7 Biologics Drug Development Market, (by Region)
7.1 Global Scenario
7.2 North America
7.2.1 The U.S.
7.2.2 Canada
7.3 Europe
7.3.1 The U.K.
7.3.2 Germany
7.3.3 France
7.3.4 Switzerland
7.3.5 Rest-of-Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 South Korea
7.4.4 India
7.4.5 Rest-of-Asia-Pacific
7.5 Rest-of-the-World (RoW)
8 Company Profiles
8.1 AbbVie Inc.
8.1.1 Abbvie Inc. : Overview
8.1.2 Abbvie Inc.: Overall Product Portfolio
8.1.2.1 Product Offerings for Global Biologics Drug Development Market
8.1.3 Financials
8.1.3.1 Financial Summary
8.1.4 SWOT Analysis
8.2 Allergan
8.2.1 Allergan Plc: Overview
8.2.2 Allergan Plc: Overall Product Portfolio
8.2.2.1 Product Offerings for Global Biologics Drug Development Market
8.2.3 Financials
8.2.3.1 Financial Summary
8.2.4 SWOT Analysis
8.3 Amgen, Inc.
8.3.1 Amgen, Inc.: Overview
8.3.2 Amgen, Inc.: Overall Product Portfolio
8.3.2.1 Product Offerings for Global Biologics Drug Development Market
8.3.3 Financials
8.3.3.1 Financial Summary
8.3.4 SWOT Analysis
8.4 Boehringer Ingelheim International GmbH
8.4.1 Boehringer Ingelheim International GmbH: Overview
8.4.2 Boehringer Ingelheim International GmbH: Overall Product Portfolio
8.4.2.1 Product Offerings for Global Biologics Drug Development Market
8.4.3 Financials
8.4.3.1 Financial Summary
8.4.4 SWOT Analysis
8.5 Catalent Inc.
8.5.1 Catalent Inc.: Overview
8.5.2 Catalent Inc.: Overall Product Portfolio
8.5.2.1 Product Offerings for Global Biologics Drug Development Market
8.5.3 Financials
8.5.3.1 Financial Summary
8.5.4 SWOT Analysis
8.6 Charles River Laboratories
8.6.1 Charles River Laboratories: Overview
8.6.2 Charles River Laboratories: Overall Product Portfolio
8.6.2.1 Product Offerings for Global Biologics Drug Development Market
8.6.3 Financials
8.6.3.1 Financial Summary
8.6.4 SWOT Analysis
8.7 FUJIFILM Diosynth Biotechnologies U.S.A., Inc
8.7.1 FUJIFILM Diosynth Biotechnologies U.S.A., Inc: Overview
8.7.2 FUJIFILM Holdings Corporation: Parent Company Overview
8.7.3 FUJIFILM Holdings Corporation: Overall Product Portfolio
8.7.3.1 Product Offerings for Global Biologics Drug Development Market
8.7.4 Financials
8.7.4.1 Financial Summary
8.7.5 SWOT Analysis
8.8 KBI Biopharma
8.8.1 KBI Biopharma: Overview
8.8.2 Corporate Summary
8.8.3 Product Offerings for Global Biologics Drug Development Market
8.8.4 SWOT Analysis
8.9 Lonza
8.9.1 Lonza: Overview
8.9.2 Lonza: Overall Product Portfolio
8.9.2.1 Product Offerings for Global Biologics Drug Development Market
8.9.3 Financials
8.9.3.1 Financial Summary
8.9.4 SWOT Analysis
8.10 MabPlex Inc.
8.10.1 MabPlex Inc.: Overview
8.10.2 Corporate Summary
8.10.3 Product Offerings for Global Biologics Drug Development Market
8.10.4 SWOT Analysis
8.11 Patheon
8.11.1 Patheon: Overview
8.11.2 Thermo Fisher Scientific, Inc.: Parent Company Overview
8.11.3 Thermo Fisher Scientific, Inc.: Overall Product Portfolio
8.11.3.1 Product Offerings for Global Biologics Drug Development Market
8.11.4 Thermo Fisher Scientific: Financials
8.11.4.1 Financial Summary
8.11.5 SWOT Analysis
8.12 Samsung BioLogics
8.12.1 Samsung BioLogics: Overview
8.12.2 Samsung BioLogics: Overall Product Portfolio
8.12.2.1 Product Offerings for Global Biologics Drug Development Market
8.12.3 Financials
8.12.3.1 Financial Summary
8.12.4 SWOT Analysis
8.13 SANOFI
8.13.1 SANOFI: Overview
8.13.2 SANOFI: Overall Product Portfolio
8.13.2.1 Product Offerings for Global Biologics Drug Development Market
8.13.3 Financials
8.13.3.1 Financial Summary
8.13.4 SWOT Analysis
8.14 Singota Solutions
8.14.1 Singota Solutions: Overview
8.14.2 Corporate Summary
8.14.3 Product Offerings for Global Biologics Drug Development Market
8.14.4 SWOT Analysis
8.15 WuXi Biologics
8.15.1 WuXi Biologics: Overview
8.15.2 WuXi Biologics: Overall Product Portfolio
8.15.2.1 Product Offerings for Global Biologics Drug Development Market
8.15.3 Financials
8.15.3.1 Financial Summary
8.15.4 SWOT Analysis
9 Consumer Perception(Pharmaceutical Companies) on Clinical Manufacturing of Biologics Drugs
10 Report Scope and Methodology
10.1 Scope of the Report
10.2 Global Biologics Drug Development Market Segmentation
10.3 Research Methodology
10.3.1 Data Triangulation
10.3.2 Key Data Points from Secondary Sources
10.3.3 Key Data Points from Primary Sources
10.3.4 Top-Down Approach (Segmental Analysis)
10.3.5 Bottom-Up Approach (Segmental Analysis)
10.4 Assumptions and Limitations
10.5 Data and Prediction Modelling
List of Tables
Total Regional Geriatric Population (by Region %), 2015 and 2030
Drug Approvals by FDA
Impact of Market Drivers
Impact of Market Restraints
Key Market Players in Biologics Drug Development
Biologics Drug Development Cost Per Molecule ($Million)
Biosimilars Drug Development Cost Per Molecule ($Million
Manufacturing Cost Per Gram ($/gm)
Global Volume Production by Company Type ($Million)
Impact of Market Drivers
Impact of Market Restraints
R&D Expenditure of a Few Companies
Factors Affecting Bargaining Power of Suppliers
Factors Affecting the Bargaining Power of Buyers
Factors Affecting Threat of New Entrant
Factors Affecting the Threat of Substitutes
Factors Affecting the Intensity of Competitive Rivalry
Global Biologics Development Market, by Class, 2017-2027, ($Million)
Sales of Major Monoclonal Antibodies, 2015
Clinical Manufacturing Market Volume by Phase (Kilograms)
Clinical Manufacturing Market Value by Phase ($Million)
Capacity Control for Biologics
Manufacturing Capacity (by Company)
North America Biologics Drug Development Market by Facility (Kg)
North America Biologics Drug Development Market by Facility ($Million)
Europe Biologics Drug Development Market by Facility (Kg)
Europe Biologics Drug Development Market by Facility ($Million)
Asia Pacific Biologics Drug Development Market by Facility (Kg)
Asia-Pacific Biologics Drug Development Market by Facility ($Million)
Abbvie Inc: Overview
Allergan Plc: Overview
Amgen, Inc.: Overview
Boehringer Ingelheim International GmbH.: Overview
Catalent Inc: Overview
Charles River Laboratories: Overview
FUJIFILM Diosynth Biotechnologies: Overview
FUJIFILM Holdings Corporation: Overview
KBI Biopharma: Overview
Lonza: Overview
MabPlex Inc.: Overview
Patheon: Overview
Thermo Fisher Scientific, Inc: Overview
Samsung BioLogics: Overview
SANOFI: Overview
SANOFI: Product Portfolio for Global Biologics Drug Development Market
Singota Solutions: Overview
WuXi Biologics: Overview
List of Figures
Global Biologics Drug Development Market ($Billion)
Global Biologics Drug Development Market (by Class), 2017
Global Biologics Drug Development Market (by Class), 2027
Global Biologics Drug Development Market (by Facility), 2017
Global Biologics Drug Development Market (by Facility), 2027
Global Biologics Drug Development Market (by Services), 2017
Global Biologics Drug Development Market (by Services), 2027
Global Biologics Drug Development Market (by Region), 2017
Global Biologics Drug Development Market (by Region), 2027
Integrated Discovery, Development, and Commercialization of Biologics
Clinical Developmental Stages
Manufacturing Stages of Biologics
Stages of Drug Development Process
Stages of Biomanufacturing
Work Flow of Upstream Development and Downstream Purification
Stages of Formulation Development
Market Dynamics
Share of Key Developmental Strategies: January 2011 to August 2018
Share of Acquisitions (by Company)
Share of Agreements, Partnerships, Joint Ventures and Collaborations (by Company)
Share of Approvals (by Company)
Share of Clinical Study (by Company)
Share of Business Expansion (by Company)
Share of Product Launch (by Company)
Share of Awards (by Company)
Porter’s Five Forces Analysis
Biologics Drug Development (by Class)
Global mAbs Development Market, 2017-2027
Global Hormones Development Market, 2017-2027
Global Growth Factors Development Market, 2017-2027
Global Cytokines and Fusion Proteins Development Market, 2017-2027
Global Therapeutic Enzymes Development Market, 2017-2027
Global Blood Factors and Anticoagulants Development Market, 2017-2027
Global Vaccines Development Market, 2017-2027
Types of Facilities
Global Biologics Drug Development Market,(by Facility Volume) 2017-2027
Global Biologics Drug Development Market, (by Facility Value) 2017-2027
Global Biologics In-House Drug Development Market, (by Volume) 2017-2027
Global Biologics In-House Drug Development Market, (by Value) 2017-2027
Global Biologics Outsource Drug Development Market, (by Volume), 2017-2027
Global Biologics Outsource Drug Development Market, (by Value), 2017-2027
Global Biologics Pharma Excess Drug Development Market , (by Volume), 2017-2027
Global Biologics Pharma Excess Drug Development Market, (by Value), 2017-2027
Types of Services
Global Biologics Drug Development Market, (by Services), 2017-2027
Global Biologics Clinical Manufacturing Services Market, 2017-2027
Global Biologics Clinical Manufacturing Services Market, (by Drug Type Volume), 2017-2027
Global Biologics Clinical Manufacturing Services Market, (by Drug Type Value), 2017-2027
Global Biologics Cell Bank and Cell Line Development Service Market , 2017-2027
Global Biologics Cell Culture Upstream Development Market, 2017-2027
Global Biologics Purification Downstream Development Market, 2017-2027
Concentration Of Global Biopharmaceutical Manufacturing
Global Biologics Formulation Development Market, 2017-2027
Global Biologics Bioassay Development Market, 2017-2027
Global Biologics Analytical Services Market, 2017-2027
Global Biologics Drug Development Market, (by Regional Volume) 2017-2027
Global Biologics Drug Development Market, (by Regional Value) 2017 -2027
North America Biologics Drug Development Market, (by Volume) 2017 -2027
North America Biologics Drug Development Market, (by Value) 2017 -2027
The U.S. Biologics Drug Development Market, (by Value) 2017 -2027
Canada Biologics Drug Development Market, (by Value) 2017 -2027
Europe Biologics Drug Development Market, (by Volume) 2017 -2027
Europe Biologics Drug Development Market, (by Value) 2017 -2027
The U.K. Biologics Drug Development Market, (by Value) 2017 -2027
Germany Biologics Drug Development Market, (by Value) 2017 -2027
France Biologics Drug Development Market, (by Value) 2017 -2027
Switzerland Biologics Drug Development Market, (by Value) 2017 -2027
Rest-of-Europe Biologics Drug Development Market, (by Value) 2017 -2027
Asia Pacific Biologics Drug Development Market, (by Volume) 2017 -2027
Asia Pacific Biologics Drug Development Market, (by Value) 2017 -2027
Japan Biologics Drug Development Market, (by Value) 2017 -2027
China Biologics Drug Development Market, (by Value) 2017 -2027
South Korea Biologics Drug Development Market, (by Value) 2017 -2027
India Biologics Drug Development Market, (by Value) 2017 -2027
Rest-of-Asia-Pacific Biologics Drug Development Marke, (by Value) 2017 -2027
Rest-of-the-World Biologics Drug Development Market, (by Volume) 2017 -2027
Rest-of-the-World Biologics Drug Development Market, (by Value) 2017 -2027
Contribution of Various Companies
AbbVie Inc.:Overall Product Portfolio
AbbVie Inc.: Product Portfolio for Global Biologics Drug Development Market
AbbVie Inc.: Overall Financials 2015-2017
AbbVie Inc.: Revenue (by Geography) 2015-2017
AbbVie Inc.: SWOT Analysis
Allergan Plc: Overall Product Portfolio
Allergan Plc: Services for Global Biologics Drug Development Market
Allergan Plc: Overall Financial 2015-2017
Allergan: Net Revenue, (by Business Segment) 2015-2017
Allergan Plc: SWOT Analysis
Amgen, Inc.: Overall Product Portfolio
Amgen, Inc.: Services for Global Biologics Drug Development Market
Amgen, Inc. : Overall Financials 2015-2017
Amgen, Inc. : Revenue (by Geography) 2015-2017
Amgen, Inc. : SWOT Analysis
Boehringer Ingelheim International GmbH: Overall Product Portfolio
Boehringer Ingelheim International GmbH: Product Portfolio for Global Biologics Drug Development Market
Boehringer Ingelheim International GmbH: Overall Financials 2015-2017
Boehringer Ingelheim International GmbH : Revenue (by Geography) 2015-2017
Boehringer Ingelheim International GmbH : Revenue (by Business Segment) 2015
Boehringer Ingelheim International GmbH: Revenue (by Business Segment) 2016-2017
Boehringer Ingelheim International GmbH: SWOT Analysis
Catalent Inc.: Overall Product Portfolio
Catalent Inc.: Services for Global Biologics Drug Development Market
Catalent, Inc.: Overall Financial 2015-2017
Catalent, Inc.: Net Revenue (by Business Segment) 2015-2017
Catalent Inc.: Net Revenue (by Region) 2015-2017
Catalent Inc.: SWOT Analysis
Charles River: Overall Product Portfolio
Charles River Laboratories: Services and Products for Global Biologics Drug Development Market
Charles River Laboratories: Overall Financial 2015-2017
Charles River: Net Revenue (by Business Segment) 2015-2017
Charles River: Net Revenue (by Region) 2015-2017
Charles River: SWOT Analysis
FUJIFILM Holdings Corporation: Overall Product Portfolio
FUJIFILM Diosynth Biotechnologies U.S.A., Inc. : Product Portfolio for Global Biologics Drug Development Market
FUJIFILM Holdings Corporation: Overall Financial 2015-2016
FUJIFILM Holdings Corporation: Net Revenue (by Business Segment) 2015-2016
FUJIFILM Holdings Corporation: Net Revenue (by Region) 2016
FUJIFILM Holdings Corporation- SWOT Analysis
KBI Biopharma: Services for Global Biologics Drug Development Market
KBI Biopharma.: SWOT Analysis
Lonza: Overall Product Portfolio
Lonza: Services for Global Biologics Drug Development Market
Lonza: Overall Financial 2015-2017
Lonza: Net Revenue (by Business Segment) 2015-2017
Lonza: Net Revenue (by Region) 2015-2016
Lonza: Net Revenue (by Region) 2017
Lonza: SWOT Analysis
MabPlex Inc. Solutions: Services for Global Biologics Drug Development Market
MabPlex Inc.: SWOT Analysis
Thermo Fisher Scientific Inc.: Overall Product Portfolio
Patheon: Product Portfolio for Global Biologics Drug Development Market
Thermo Fisher Scientific, Inc.: Overall Financial 2015-2017
Thermo Fisher Scientific, Inc.: Net Revenue (by Business Segment) 2015-2017
Thermo Fisher Scientific, Inc.: Net Revenue (by Region) 2015-2017
Thermo Fisher Scientific Inc.- SWOT Analysis
Samsung BioLogics: Overall Product Portfolio
Samsung BioLogics: Services for Global Biologics Drug Development Market
Samsung BioLogics: Overall Financial 2015-2017
Samsung BioLogics: Net Revenue (by Business Unit) 2015-2017
Samsung BioLogics: SWOT Analysis
SANOFI: Overall Product Portfolio
SANOFI: Product Portfolio for Global Biologics Drug Development Market
Sanofi : Overall Financials 2015-2017
Sanofi : Revenue (by Business Segment) 2015
Sanofi : Revenue ( by Business Segment) 2016-2017
Sanofi : Revenue (by Geography) 2015
Sanofi : Revenue (by Geography) 2016-2017
SANOFI: SWOT Analysis
Singota Solutions: Services for Global Biologics Drug Development Market
Singota Solutions: SWOT Analysis
WuXi Biologics: Overall Product Portfolio
WuXi Biologics: Services for Global Biologics Drug Development Market
Wuxi Biologics: Overall Financial 2015-2017
Wuxi Biologics: Net Revenue (by Region) 2016-2017
WuXi Biologics: SWOT Analysis
Research Methodology
Data Triangulation
Key Data Points From Secondary Sources
Key Data Points From Primary Sources
Top-Down Approach (Segmental Analysis)
Bottom-Up Approach (Segmental Analysis)
Assumptions and Limitations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report